In a press conference in Cairo today, 14 November, the Egyptian Drug Authority (EDA) announced the start of the first phase of clinical trials on an Egyptian COVID-19 vaccine, following success of pre-clinical trials.
The Egyptian vaccine goes under the name Covi Vax.
v
The press conference was held by the Ministry of Higher Education and Scientific Research at the National Research Centre (NRC) in Cairo. The vaccine was developed jointly by the NRC and the pharmaceutical company Vaccine Valley.
The EDA said it had provided and will continue to provide full technical support for the vaccine development.
Watani International
14 November 2021